Cannabis
Fire & Flower Completes Bought Deal Financing
Fire & Flower Holdings Corp. (“Fire & Flower” or the “Company“) (TSXV: FAF), today announced the closing of its previously announced bought deal private placement (the “Private Placement“) of 27,188 convertible debenture units (the “Units“) at a price of $1,000 per Unit for aggregate gross proceeds of $27,188,000. Each Unit is comprised of one $1,000 principal amount unsecured convertible debenture (a “Convertible Debenture“) and 278 common share purchase warrants (each, a “Warrant“). Each Warrant entitles the holder thereof to purchase one common share in the capital of the Company (a “Warrant Share“) for a period of 24 months following the closing of the Private Placement at an exercise price of $1.45 per Warrant Share.
“With the recent re-opening of cannabis retail licensing in Alberta, being able to accelerate store build-outs is key” shared Trevor Fencott, Fire & Flower’s Chief Executive Officer. “Access to capital is critical to success in a growth industry, and this financing clearly puts Fire & Flower in a position to capitalize on market opportunities as they emerge.”
The Private Placement was underwritten by a syndicate of underwriters, led by Eight Capital and GMP Securities L.P. and including AltaCorp Capital Inc., Canaccord Genuity Corp. and Echelon Wealth Partners Inc. (collectively, the “Underwriters“).
The Convertible Debentures bear interest at an annual rate of 8.00% payable in arrears in equal installments semi-annually. The Convertible Debentures mature on June 26, 2020 (the “Maturity Date“). The principal amount of Convertible Debenture and accrued and unpaid interest thereon will be convertible at the holder’s option into common shares of the Company (the “Conversion Shares“) at any time prior to the earlier of: (a) the close of business on the business day immediately preceding the Maturity Date; and (b) the date fixed for redemption (as set out in the Debenture Indenture (as defined below)). The conversion price for the principal amount of Convertible Debentures is $1.20 per Conversion Share. The conversion price for the accrued and unpaid interest is the greater of (a) $1.20; and (b) the Market Price (as defined in the policies of the TSX Venture Exchange) on the date of conversion, per Conversion Share. The conversion of the Convertible Debentures is subject to adjustment in certain events as described in a debenture indenture dated as of June 26, 2019 entered into between the Company and Computershare Trust Company of Canada (the “Debenture Indenture“).
In connection with the Private Placement, Fire & Flower has paid the Underwriters aggregate cash consideration of $1,476,420. As additional consideration, the Underwriters have received 1,355,350 compensation options (“Compensation Options“) in connection with the Private Placement. Each Compensation Option is exercisable for one common share of the Company at a price of $1.20 per share until June 26, 2021.
The net proceeds of the Private Placement will be used for working capital and general corporate purposes, including to grow the Company’s proprietary Hifyre digital platform.
Certain directors and officers of the Company participated in the Private Placement and purchased an aggregate of 150 Units. Such participation constitutes a related-party transaction under Multilateral Instrument 61-101-Protection of Minority Security Holders in Special Transactions (“MI 61-101“). The Company has relied on exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101 in respect of related party participation in the Private Placement as neither the fair market value (as determined under MI 61-101) of the subject matter of, nor the fair market value of the consideration for, the transaction, insofar as it involved related parties, exceeded 25% of the Company’s market capitalization as determined under MI 61-101.
SOURCE Fire & Flower Holdings Corp.
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan4 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf4 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis4 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care